Skip to main content

Table 2 Performance evaluation of ESTA X4-dual/mixed tropism prediction using geno2pheno clinical and clonal at 10% FPR, or the clonal at the optimised 5.75% FPR interpretation of contemporary viral gp120 V3 DNA or RNA genotyping

From: Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping

Viral sample

geno2pheno interpretation mode (FPR)

AUROC

accuracy

sensitivity

specificity

plasma RNA (n = 35)

Clinical (10%)

0.83

80.0%

90.9%

75.0%

 

Clonal (10%)

0.67

71.4%

54.5%

79.2%

 

Clonal optim. (5.75% )

0.75

82.9%

54.5%

95.8%

whole-blood DNA (n = 17)

Clinical (10%)

0.86

76.5%

100%

71.4%

 

Clonal (10%)

0.69

70.6%

66.7%

71.4%

 

Clonal optim. (5.75% )

0.76

82.3%

66.7%

85.7%